2018
DOI: 10.14573/altex.1703231
|View full text |Cite
|
Sign up to set email alerts
|

Use of high-throughput in vitro toxicity screening data in cancer hazard evaluations by IARC Monograph Working Groups

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
51
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(52 citation statements)
references
References 38 publications
1
51
0
Order By: Relevance
“…When the evidence from human epidemiologic studies is less than sufficient, strong mechanistic data can play a pivotal role in the overall carcinogen hazard classification ( 10 , 11 ). For instance, even though the evidence from rodent cancer bioassays provided ‘sufficient’ evidence of cancer in animals, d -limonene was classified in Group 3 (not classifiable as to its carcinogenicity to humans) on the basis of mechanistic and other relevant data because the probable mechanism of carcinogenicity in animals was unlikely to be operative in humans ( 12 ).…”
Section: Introductionmentioning
confidence: 99%
“…When the evidence from human epidemiologic studies is less than sufficient, strong mechanistic data can play a pivotal role in the overall carcinogen hazard classification ( 10 , 11 ). For instance, even though the evidence from rodent cancer bioassays provided ‘sufficient’ evidence of cancer in animals, d -limonene was classified in Group 3 (not classifiable as to its carcinogenicity to humans) on the basis of mechanistic and other relevant data because the probable mechanism of carcinogenicity in animals was unlikely to be operative in humans ( 12 ).…”
Section: Introductionmentioning
confidence: 99%
“…Analysis of PFOA activity in high-throughput screening assays from the ToxCast and Tox21 programs identified that PFOA induced activity in four different estrogen receptor assays, seven peroxisome proliferator activated receptors (PPAR) and retinoid X receptor assays, one androgen receptor assay, as well as several metabolic enzyme assays [176]. PFNA, PFOS and PFHxS also activated PPARγ and estrogen receptor alpha in ToxCast assays and modulated expression of estrogen receptor-related transcriptional profiles in livers from mice exposed to these PFAS [177].…”
Section: Modulates Receptor-mediated Effectsmentioning
confidence: 99%
“…Animal Biosassay In Vitro PFOA Association: [153]; [154]; [155]; [156]; [157] Association: reviewed in [164]; [91]; [165]; [166]; [169]; [170]; [173]; [175]; [191]; [61] No association: [174] Association: [176]; [158]; [175]; [181]; [188]; [189]; [193]; [179]; [180] No association: [182] Long-chain PFAS a PFOS Association: [154]; [155]; [156]; [157]; [160]; reviwed in [163] No Association: [153] Association: [191]; [192] Association: [177]; [175]; [181]; [188]; [189]; [193]; [179]; [180] No association: [182] PFHxS Association: [159]; reviwed in [163] No association: [...…”
Section: Epidemiologicalmentioning
confidence: 99%
“…In order to address the needs for prioritization of overall burden across communities as well as for prioritization of intervention opportunities within communities simultaneously, we adapted the Toxicological Prioritization Index (ToxPi) approach to integrate the multiple data streams incorporated into HGBEnviroScreen [9,10]. ToxPi is a visual, decision-support tool that has been used to communicate risk prioritization and profiling information between scientists, regulators, stakeholders, and the general public [11][12][13]. The overall ToxPi score and accompanying graphical profile simultaneously provide both a relative ranking in terms of overall vulnerability as well as an indicator of the specific drivers of increased vulnerability.…”
Section: Introductionmentioning
confidence: 99%